|
Volumn 86, Issue 10, 2007, Pages 771-772
|
Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARSENIC TRIOXIDE;
ASCORBIC ACID;
CIPROFLOXACIN;
CYTARABINE;
DAUNORUBICIN;
ETHAMBUTOL;
IDARUBICIN;
ISONIAZID;
LAMIVUDINE;
MITOXANTRONE;
RETINOIC ACID;
RIFAMPICIN;
TACROLIMUS;
VIRUS DNA;
ADULT;
CADAVER DONOR;
CASE REPORT;
DISEASE COURSE;
DRUG DOSE REDUCTION;
DRUG WITHDRAWAL;
HEPATITIS B VIRUS;
HUMAN;
LETTER;
LEUKEMIA RELAPSE;
LEUKEMIA REMISSION;
LIVER CIRRHOSIS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MAINTENANCE THERAPY;
MALE;
MULTIPLE CYCLE TREATMENT;
OUTCOME ASSESSMENT;
POSTOPERATIVE PERIOD;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
TUBERCULOSIS;
VIRUS REACTIVATION;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARSENICALS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MALE;
OXIDES;
RNA, VIRAL;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
VIRUS ACTIVATION;
|
EID: 34548331731
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s00277-007-0318-2 Document Type: Letter |
Times cited : (3)
|
References (6)
|